Hofseth BioCare ASA: AECORBIO APPOINTS PROF. KARL G. SYLVESTER AS CO-FOUNDER AND CONSULTING CHIEF MEDICAL OFFICER
Hofseth BioCare ASA ("HBC") announces that its US spin-out AecorBio Inc. ("AecorBio") has appointed Prof. Karl G. Sylvester, M.D., as Co-Founder and Consulting Chief Medical Officer. Dr. Sylvester is Professor of Surgery at Stanford University School of Medicine and has advised AecorBio on the clinical strategy for FT-002a-O since 2025.